NCT06992089
SHort Of Pace - Heart Failure (SHOP-HF)
At risk: Primary completion moved at least 11 months later.
See at-risk trials from Fundación para la Investigación del Hospital Clínico de Valencia
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Jun 2026 to Jun 2027
- Eligibility criteria shortened, about 4 words
- Interventions modified
- Secondary endpoints: details revised at 1 of 6 entries
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Start date changed from estimate of Jun 15, 2025 to Jun 17, 2025
- Minor Start date: May 20, 2025 to Jun 15, 2025v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (6)
Show 1 moreShow less
Arms and interventions
Pacemaker stimulation programmed as AAIR / DDDR / VVIR with the basic stimulation frequency and the rate response as follows (pacing on): * Basic heart rate: derived from the averaged resting heart rates of healthy adults according to height and LVEF. * Rate response through a combination of minute ventilation and accelerometer, with an accelerometer response factor between 3 and 8 and an activity threshold ranging from medium-low to medium. Within these ranges, settings will be individualised by the investigator according to the participant's chronotropic response, activity profile and clinical tolerance. Each adjustment will be documented in the source records and case report form. These programming criteria will also apply when pacing-on is initiated at crossover.
VVI 30 bpm
Devices: Dual-chamber cardiac pacemaker (Proponent MRI L211/L231 or Accolade MRI L311/L331, Boston Scientific), single-chamber cardiac pacemaker (Essentio MRI L110 or Accolade MRI L310, Boston Scientific)
Sites
1 site in 1 country
- Hospital Clínico de la Comunidad ValencianaValencia, Spain